Knight Therapeutics | GUD - Betriebsaufwand

Aktienkurs
6.41
Täglich Wechseln
0.11 1.75%
Monatlich
-2.29%
Jährlich
3.72%
Q1 Prognose
6.25




Betriebsaufwand Veränderung Datum
Acasti Pharma USD 62.82M 59.73M 2025-09
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alaunos Therapeutics USD 1.19M 148K 2025-09
Aurora Cannabis CAD 129.98M 16.05M 2025-12
Avita Medical AUD 28.02M 1.55M 2025-12
Canopy Growth CAD 87.2M 6.22M 2025-12
Cronos Group USD 51.59M 70.5M 2025-12
Dianthus Therapeutics USD 69.82M 29.14M 2025-12
Ionis Pharmaceuticals USD 418M 101.1M 2025-12
IQVIA Holdings USD 1.69B 4.47B 2025-12
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Moderna USD 1.54B 259M 2025-12
Omeros USD 59.16M 20.13M 2024-06
Organigram Holdings CAD 83.66M 24.44M 2025-12
Organon & Co USD 906M 362M 2025-09
Revvity USD 626.22M 25.62M 2025-12
Tectonic Therapeutic USD 21.52M 374K 2025-12
Tilray USD 237.52M 17.34M 2025-09
Viatris USD 3.86B 335.7M 2025-12
Xeris Pharmaceuticals USD 69.03M 1.38M 2025-12